Previous haemodynamic studies in our laboratory have shown that pulmonary arterial and arterial wedge pressures in patients with isolated mitral stenosis decreased after administration of propranolol, without significant changes in right heart filling pressures or stroke volume.
Reduction of left heart filling and pulmonary arterial pressures in patients with mitral stenosis by parenterally administered beta adrenergic blocking agents has been documented by several investigators (Howitt, Tinker, and Wade, I965; Tsolkas, Davies, and Oram, I965; Cumming and Carr, I966; Goyle et al., I969) . It has been, however, suggested that the negative inotropic effects of beta adrenergic blockade, by reducing cardiac output (Howitt et al., i965; Stavropoulos, Davies, and Gazetopoulos, I965; Bensaid, Scebat, and Lenegre, I970), and the increase of ventricular filling pressures (Cummuing and Carr, I966), may negate these beneficial effects. However, in our studies on patients with isolated mitral stenosis (Goyle et al., I969) , the negative chronotropic effect of propranolol appeared to be the dominant factor responsible for the observed circulatory effects. The present study was designed to verify these observations further.
Patients and methods of study Five patients, 2 men and 3 women, aged 2I to 38 years, with isolated rheumatic mitral stenosis were studied. Four patients were in normal sinus
Received II August 1971. rhythm. The fifth patient, who was in normal sinus rhythm before cardiac catheterization, developed atrial fibrillation during the early part of the study. No patient was currently receiving digitalis preparations.
A No. 7 French, Goodale Lubin Cardiac catheter was introduced via the right median basilic vein and its tip was manoeuvred into the main pulmonary artery under fluoroscopic control. A NBIH bipolar pacing catheter was introduced through the same or a different right arm vein and placed at a site in the right atrium consistent with complete capture of cardiac rhythm, when paced with an extemal fixed rate pacemaker. In the patient with atrial fibrillation, cardiac rate was controlled by right ventricular pacing. The right brachial artery was cannulated with a Teflon arterial needle and used as a site for monitoring pressure and for sampling blood dye mixture for recording indicator dilution curves. Dye dilution curves were obtained by injecting Evan's blue dye (5 o to 7-5 mg) into the pulmonary artery and sampling the blood dye mixture at the peripheral arterial site, through a Colson cuvette densitometer (Model I-103) at a constant withdrawal rate of 25 ml/min. Pressures were obtained using Statham P23Db pressure transducers. Mean pressures were recorded by electronic integration. Baseline for all pressure measurement was at half the chest thickness at second costal cartilage with the patient supine (Roy, Gadboys, and Dow, 1957 No consistent change in cardiac index was noted with pacing. It was also unaffected by administration of propranolol while the heart was paced but decreased to 2*9 1./min/m2 after stopping cardiac pacing, a statistically significant change from the pacing value (P < o0oi).
Pacing before and after propranolol administration resulted in almost identical stroke indices (36.i and 37-2 ml/beats/ml2), a value lower than the control stroke index (40-6 ml/ beat/M2). However, the post-pacing stroke index under the effect of beta adrenergic blockade was almost the same (4II ml/beat/ m2n) as the control stroke index.
With changes in heart rate, the diastolic filling period per beat was insignificantly reduced, the control diastolic filling period of o0390 sec/beat, decreasing to o0329 and o0335 sec/beat respectively during pacing, before and after administration of propranolol. However, conspicuous prolongation of this interval was noted (mean o0529 sec/beat) in the post-pacing period (P < ooi).
Pulmonary artery, pulmonary arterial wedge, left ventricular (diastolic) pressures, transmitral pressure gradient, and pulmonaryvascular resistance (Table  I, mmHg) was almost the same as control (26-6 mmHg). It was unchanged by propranolol at a fixed paced heart rate. However, a significant reduction (mean 2I.3 mmHg P<o-oi) was noted after stopping pacing.
Pulmonary arterial wedge pressure was also slightly increased during pacing. It was, however, unaffected by propranolol while pacing was continued. However, when cardiac pacing was terminated, pulmonary wedge pressure decreased significantly (P < 0-02) as compared to the paced value.
Reduction of pulmonary arterial wedge pressure was closely related to changes in heart rate and diastolic filling period (Fig. 4) , but not to changes of blood flow across the mitral valve.
A variable change in pulmonary vascular resistance occurred during cardiac pacing both before and after administration of propranolol. Likewise, the post-pacing pulmonary vascular resistance was variably changed (increased in two patients, and slightly decreased heart rate (HR), stroke index (SI), and diastolic filling period (DFP), during fixed rate cardiac pacing in patients with mitral stenosis. Propranolol (PNG + PRL) did not affect the stroke index of paced (PNG) patients. However, after stopping pacing (PRL) stroke index increased in all instances. A conspicuous prolongation of diastolic filling period (DFP) also occurred when pacing was stopped after injection of propranolol, while during pacing it caused no such change (C, control data).
in another and decreased in the fourth patient) as compared to pacing values.
Left ventricular end-diastolic pressure (Fig.  3) , which was normal at rest in 2 of the 3 patients, decreased with pacing in all instances and was unaffected by propranolol while pacing was continued. Furthermore, the left ventricular end-diastolic pressure was insignificantly changed when pacing was stopped and only the effects of propranolol were still manifest.
A significant pressure gradient across the mitral valve present at rest increased slightly further with cardiac pacing before and after propranolol administration, but decreased in all instances to either control or even lower levels in the post-pacing phase. However, all these changes were of no statistical significance.
Discussion
The raised left atrial pressure in patients with mitral stenosis is related to several factors, of which the size of the mitral orifice, flow across the valve during diastole, the duration of the diastolic filling period, and the left ventricular diastolic pressures are most important. In an individual patient the size of mitral orifice being fixed, left atrial pressure would be related to the latter factors and an increased blood flow, a decreased diastolic filling period, and an increase in left ventricular diastolic pressure would all lead to an increased pressure in the left atrium and vice versa. Beta adrenergic blocking agents, because of the negative inotropic and chronotropic effects, may be expected to reduce flow and increase the diastolic filling period with consequent reduction of left atrial and pulmonary arterial with mitral stenosis, with atrial fibrillation, or in normal sinus rhythm have been different and more consistent (Goyle et al., I969) . The resting pulmonary artery and arterial wedge pressures were found to decrease in almost all instances, with no significant change of stroke volume, but a significant prolongation of the diastolic filling period as a consequence of slowing of the heart rate. Data obtained in the present study confirm the importance of the negative chronotropic effect of propranolol in producing the observed haemodynamic effects in patients with mitral valvular obstruction. As long as the heart rate was kept constant by fixed rate pacing, beta adrenergic blockade produced no significant changes of pulmonary arterial or pulmonary arterial wedge pressures. However, the effects became evident in the immediate post-pacing period. Since the stroke volume was, if anything, a little higher at this time, a factor that should result in an increase of pulmonary pressures, the net decrease indicates that prolongation of the diastolic filling period was the main factor involved in the observed pressure changes. Our findings are in contrast to the recently reported effect of another beta adrenergic blocking agent -oxprenolol -in paced patients with mitral stenosis, reported by Bensaid et al. (1970) . These investigators observed no significant change of pulmonary arterial mean pressure, a slight reduction of heart rate, but a significant fall of cardiac index (P <o-oi) and stroke index (P <o0o5). They have suggested that the presence of a fixed obstacle, as in mitral stenosis, unmasks the negative inotropic effects of the drug. The variability of these results in contrast to those observed in our study may be related to the rather high dose of oxprenolol (o02 mg/kg) used to elicit the response. It is possible that in this high concentration, oxprenolol may Negative inotropic effects of propranolol have been considered to negate the usefulness of beta adrenergic blocking drugs in mitral stenosis (Cumming and Carr, I966) . However, our data show that neither the right heart filling pressures (Goyle et al., I969) nor the left ventricular diastolic pressures (present study) are significantly affected in such patients. Such a fear may, therefore, be unwarranted in selected patients.
Variation of our data from that of other investigators may be due to application of more rigid criteria in selection of patients with lone mitral stenosis and exclusion of those with any other valvular lesion. It may also be due to the younger age of these patients without attendant occult coronary heart disease and with possibly a healthier myocardium (Roy et al., I963) . Older patients are likely to have some myocardial disease related to either longstanding rheumatic heart disease or associated coronary or hypertensive heart disease. It is possible that such patients may develop greater depression of myocardial function with beta adrenergic blocking drugs. This suggests a cautious use of these agents in such patients. FIG . 4 A close correlation exists between heart rate (HR) pulmonary artery wedge pressure (PAW), and diastolic filling period (DFP). During pacing when heart rate and diastolic filling period were constant propranolol had no effect on PAW pressure. Reduction was however noted after pacing was stopped when the negative chronotropic effects of propranolol were manifest, with attendant reduction of heart rate and increased diastolic filling period. Stroke index at this time was unchanged as compared to the control nonpaced period, but was higher than during the period of pacing before and after administration of propranolol. 
